Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2023, Cilt: 8 Sayı: 2, 46 - 54, 30.06.2023
https://doi.org/10.58854/jicm.1279644

Öz

Destekleyen Kurum

Yok

Proje Numarası

Yok

Teşekkür

Yok

Kaynakça

  • Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, innerup NB, First MB, Giamberardino MA, Kaasa S, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. A classification of chronic pain for ICD-11. Pain. 2015 Jun;156(6):1003-1007. doi: 10.1097/j.pain.0000000000000160. PMID: 25844555; PMCID: PMC4450869.
  • Ushida T. Burdensome problems of chronic musculoskeletal pain and future prospects. J Orthop Sci. 2015 Nov;20(6):958-66. doi: 10.1007/s00776-015-0753-1. Epub 2015 Aug 11. PMID: 26260256; PMCID: PMC4664610.
  • Barke A, Korwisi B, Casser HR, Fors EA, Geber C, Schug S, Stubhaug A, Ushida T, Wetterling T, Rief W, Treede RD. Pilot field testing of the chronic pain classification for ICD-11: the results of ecological coding. BMC Public Health 2018;18:1239.
  • Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. A classification of chronic pain for ICD-11. Pain. 2015 Jun;156(6):1003-1007. doi: 10.1097/j.pain.0000000000000160.
  • Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019 Jan;160(1):77-82. doi: 10.1097/j.pain.0000000000001389.
  • Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020 Oct;125(4):436-440. doi: 10.1016/j.bja.2020.05.021. Epub 2020 May 31. PMID: 32560913; PMCID: PMC7261464.
  • Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK, Mendias CL. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847. PMID: 32675661; PMCID: PMC7508274.
  • Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK, Mendias CL. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847. PMID: 32675661; PMCID: PMC7508274.
  • Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23
  • Gallardo E, de Andr´es I, Illa I. Cathepsins are upregulated by IFN-gamma/STAT in human muscle culture: a possible active factor in dermatomyositis. J Neuropathol Exp Neurol. 2001 Sep;60(9):847-55.
  • Otis JS, Niccoli S, Hawdon N, Sarvas JL, Frye MA, Chicco AJ, Lees SJ. Pro inflammatory mediation of myoblast proliferation. PLoS One. 2014 Mar 19;9(3): e92363.
  • Shanthanna H, Cohen S, Strand N, vd. COVID-19 salgını sırasında kronik ağrı uygulaması hakkında öneriler: Amerikan Bölgesel Anestezi ve Ağrı Tıbbı Derneği (ASRA) ve Avrupa Bölgesel Anestezi ve Ağrı Tedavisi Derneği’nin (ESRA) ortak bildirisi. 2020. https://www.asra.com/page/2903/recommendations-on-chronic-pain practice-during-the-covid-19-pandemic
  • Freyd M. (1923). The graphic rating scale. Journal of Educational Psychology, 14, 83- 102.
  • Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13(4):227-36. doi: 10.1002/nur.4770130405. PMID: 2197679.
  • Organization WH. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization; 2020.
  • Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-34.
  • Scherrer KH, Ziadni MS, Kong JT, et al. Development and validation of the Collaborative Health Outcomes Information Registry body map. Pain Reports. 2021 Jan-Feb;6(1):e880. doi: 10.1097/pr9.0000000000000880.
  • Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, N., Funai, K., McDonagh, B., & Mendias C. L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis. The FASEB Journal, 2019;33(7), 7863-7881.
  • Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta analysis. J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 2020;77(6), 683-690.
  • Zhong Z, Li H, Zhu J, Ji P, Li B, Pang J, Zhang J, Liang X. Clinical characteristics of 2,459 severe or critically ill COVID-19 patients: A meta-analysis. Medicine (Baltimore). 2021;100(5):e23781. doi: 10.1097/MD.0000000000023781.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020; 395(10229), 1054-1062.
  • Tuzun S, Keles A, Okutan D, Yildiran T, Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021;57(4):653-662. doi: 10.23736/S1973-9087.20.06563-6.
  • Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, Rosaria Barillari M, Cammaroto G, Fakhry N, Martiny D, Ayad T, Jouffe L, Hopkins C, Saussez S; COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-344. doi: 10.1111/joim.13089.
  • Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides. 2007;41(6):355-63. doi: 10.1016/j.npep.2007.06.001.
  • Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., ... & Xu, H. (2020). The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv.
  • Xie J, Wang Q, Xu Y, Zhang T, Chen L, Zuo X, Liu J, Huang L, Zhan P, Lv T, Song Y. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863

The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain

Yıl 2023, Cilt: 8 Sayı: 2, 46 - 54, 30.06.2023
https://doi.org/10.58854/jicm.1279644

Öz

Amaç: Bu çalışmanın amacı, akciğer tutulumu olan ve olmayan COVID-19 hastalarında sekonder kronik kas-iskelet ağrısı gelişimini değerlendirmek ve ağrı alanlarını belirlemektir.
Yöntem: Kesitsel olarak dizayn edilen bu çalışmaya acil servise COVID-19 semptomları ile başvuran ve COVID-19 tanısı konan 18 yaş ve üzeri toplam 150 hasta dahil edildi. Bu hastaların 84'ünde akciğer tutulumu varken, 66'sında akciğer tutulumu yoktu. Tanı sürecinde ve sonrasındaki üç aylık süreçte hastalarla yüz yüze iletişim kurularak ya da akıllı telefonlardan Skype uygulaması üzerinden görüntülü görüşme yoluyla dosyalarına kaydedilen verilere ulaşıldı. Katılımcılardan, “İşbirlikçi Sağlık Sonuçları Bilgi Kaydı” vücut haritasında ağrı alanlarını işaretlemeleri ve Vizüel Analog Skala kullanarak ağrı yoğunluklarını 1-10 arasında derecelendirmeleri istendi.
Bulgular: Vizüel Analog Skala 'da belirtilen maksimum akut kas-iskelet ağrısı derecesinin akciğer tutulumu olan hastalarda akciğer tutulumu olmayanlara göre daha düşük olduğu görüldü. Akciğer tutulumu olan hastalarda karın bölgesi dışında akut ağrı ve kronik ağrı oranları da akciğer tutulumu olmayanlara göre daha düşüktü.
Sonuç: Akciğer tutulumu olan COVID-19 hastalarında, stres ve inflamatuar yanıta sekonder stres analjezi gelişmesi nedeniyle kronik kas-iskelet sistemi ağrı derecesi daha düşük olabilir. Bu konuda daha kapsamlı çalışmalara ihtiyaç vardır.

Proje Numarası

Yok

Kaynakça

  • Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, innerup NB, First MB, Giamberardino MA, Kaasa S, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. A classification of chronic pain for ICD-11. Pain. 2015 Jun;156(6):1003-1007. doi: 10.1097/j.pain.0000000000000160. PMID: 25844555; PMCID: PMC4450869.
  • Ushida T. Burdensome problems of chronic musculoskeletal pain and future prospects. J Orthop Sci. 2015 Nov;20(6):958-66. doi: 10.1007/s00776-015-0753-1. Epub 2015 Aug 11. PMID: 26260256; PMCID: PMC4664610.
  • Barke A, Korwisi B, Casser HR, Fors EA, Geber C, Schug S, Stubhaug A, Ushida T, Wetterling T, Rief W, Treede RD. Pilot field testing of the chronic pain classification for ICD-11: the results of ecological coding. BMC Public Health 2018;18:1239.
  • Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. A classification of chronic pain for ICD-11. Pain. 2015 Jun;156(6):1003-1007. doi: 10.1097/j.pain.0000000000000160.
  • Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019 Jan;160(1):77-82. doi: 10.1097/j.pain.0000000000001389.
  • Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020 Oct;125(4):436-440. doi: 10.1016/j.bja.2020.05.021. Epub 2020 May 31. PMID: 32560913; PMCID: PMC7261464.
  • Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK, Mendias CL. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847. PMID: 32675661; PMCID: PMC7508274.
  • Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK, Mendias CL. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847. PMID: 32675661; PMCID: PMC7508274.
  • Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23
  • Gallardo E, de Andr´es I, Illa I. Cathepsins are upregulated by IFN-gamma/STAT in human muscle culture: a possible active factor in dermatomyositis. J Neuropathol Exp Neurol. 2001 Sep;60(9):847-55.
  • Otis JS, Niccoli S, Hawdon N, Sarvas JL, Frye MA, Chicco AJ, Lees SJ. Pro inflammatory mediation of myoblast proliferation. PLoS One. 2014 Mar 19;9(3): e92363.
  • Shanthanna H, Cohen S, Strand N, vd. COVID-19 salgını sırasında kronik ağrı uygulaması hakkında öneriler: Amerikan Bölgesel Anestezi ve Ağrı Tıbbı Derneği (ASRA) ve Avrupa Bölgesel Anestezi ve Ağrı Tedavisi Derneği’nin (ESRA) ortak bildirisi. 2020. https://www.asra.com/page/2903/recommendations-on-chronic-pain practice-during-the-covid-19-pandemic
  • Freyd M. (1923). The graphic rating scale. Journal of Educational Psychology, 14, 83- 102.
  • Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13(4):227-36. doi: 10.1002/nur.4770130405. PMID: 2197679.
  • Organization WH. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. World Health Organization; 2020.
  • Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-34.
  • Scherrer KH, Ziadni MS, Kong JT, et al. Development and validation of the Collaborative Health Outcomes Information Registry body map. Pain Reports. 2021 Jan-Feb;6(1):e880. doi: 10.1097/pr9.0000000000000880.
  • Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, N., Funai, K., McDonagh, B., & Mendias C. L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis. The FASEB Journal, 2019;33(7), 7863-7881.
  • Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta analysis. J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757.
  • Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 2020;77(6), 683-690.
  • Zhong Z, Li H, Zhu J, Ji P, Li B, Pang J, Zhang J, Liang X. Clinical characteristics of 2,459 severe or critically ill COVID-19 patients: A meta-analysis. Medicine (Baltimore). 2021;100(5):e23781. doi: 10.1097/MD.0000000000023781.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020; 395(10229), 1054-1062.
  • Tuzun S, Keles A, Okutan D, Yildiran T, Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med. 2021;57(4):653-662. doi: 10.23736/S1973-9087.20.06563-6.
  • Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, Rosaria Barillari M, Cammaroto G, Fakhry N, Martiny D, Ayad T, Jouffe L, Hopkins C, Saussez S; COVID-19 Task Force of YO-IFOS. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-344. doi: 10.1111/joim.13089.
  • Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides. 2007;41(6):355-63. doi: 10.1016/j.npep.2007.06.001.
  • Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., ... & Xu, H. (2020). The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv.
  • Xie J, Wang Q, Xu Y, Zhang T, Chen L, Zuo X, Liu J, Huang L, Zhan P, Lv T, Song Y. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863
Toplam 27 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular İç Hastalıkları
Bölüm Araştırma Makaleleri
Yazarlar

İbrahim Başhan

Gülşah Yaşa Öztürk

Proje Numarası Yok
Erken Görünüm Tarihi 30 Haziran 2023
Yayımlanma Tarihi 30 Haziran 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 8 Sayı: 2

Kaynak Göster

APA Başhan, İ., & Yaşa Öztürk, G. (2023). The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. Journal of Immunology and Clinical Microbiology, 8(2), 46-54. https://doi.org/10.58854/jicm.1279644
AMA Başhan İ, Yaşa Öztürk G. The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. J Immunol Clin Microbiol. Haziran 2023;8(2):46-54. doi:10.58854/jicm.1279644
Chicago Başhan, İbrahim, ve Gülşah Yaşa Öztürk. “The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain”. Journal of Immunology and Clinical Microbiology 8, sy. 2 (Haziran 2023): 46-54. https://doi.org/10.58854/jicm.1279644.
EndNote Başhan İ, Yaşa Öztürk G (01 Haziran 2023) The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. Journal of Immunology and Clinical Microbiology 8 2 46–54.
IEEE İ. Başhan ve G. Yaşa Öztürk, “The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain”, J Immunol Clin Microbiol, c. 8, sy. 2, ss. 46–54, 2023, doi: 10.58854/jicm.1279644.
ISNAD Başhan, İbrahim - Yaşa Öztürk, Gülşah. “The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain”. Journal of Immunology and Clinical Microbiology 8/2 (Haziran 2023), 46-54. https://doi.org/10.58854/jicm.1279644.
JAMA Başhan İ, Yaşa Öztürk G. The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. J Immunol Clin Microbiol. 2023;8:46–54.
MLA Başhan, İbrahim ve Gülşah Yaşa Öztürk. “The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain”. Journal of Immunology and Clinical Microbiology, c. 8, sy. 2, 2023, ss. 46-54, doi:10.58854/jicm.1279644.
Vancouver Başhan İ, Yaşa Öztürk G. The Relationship Between COVID-19 and Secondary Chronic Musculoskeletal Pain. J Immunol Clin Microbiol. 2023;8(2):46-54.

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM bir QMEL® Tıp & Yayınevi ürünüdür.